Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Goodwill (2016 - 2025)

Historic Goodwill for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $606.8 million.

  • Haemonetics' Goodwill rose 25.76% to $606.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $606.8 million, marking a year-over-year increase of 25.76%. This contributed to the annual value of $604.3 million for FY2025, which is 693.47% up from last year.
  • As of Q4 2025, Haemonetics' Goodwill stood at $606.8 million, which was up 25.76% from $606.1 million recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Goodwill peaked at $616.2 million during Q3 2024, and registered a low of $465.0 million during Q4 2022.
  • Moreover, its 5-year median value for Goodwill was $468.4 million (2021), whereas its average is $525.5 million.
  • In the last 5 years, Haemonetics' Goodwill soared by 12142.87% in 2021 and then plummeted by 163.28% in 2025.
  • Haemonetics' Goodwill (Quarter) stood at $468.6 million in 2021, then fell by 0.53% to $466.1 million in 2022, then increased by 19.07% to $555.0 million in 2023, then grew by 9.06% to $605.3 million in 2024, then increased by 0.26% to $606.8 million in 2025.
  • Its Goodwill was $606.8 million in Q4 2025, compared to $606.1 million in Q3 2025 and $607.3 million in Q2 2025.